RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+31.86%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$6.4B
AUM Growth
+$6.4B
(+35%)
Cap. Flow
+$641M
Cap. Flow
% of AUM
10.02%
Top 10 Holdings %
Top 10 Hldgs %
53.23%
Holding
81
New
14
Increased
12
Reduced
20
Closed
17
Top Buys
| 1 |
Arvinas
ARVN
|
$173M |
| 2 |
CRGX
CARGO Therapeutics
CRGX
|
$120M |
| 3 |
Madrigal Pharmaceuticals
MDGL
|
$117M |
| 4 |
Akero Therapeutics
AKRO
|
$83.9M |
| 5 |
Alkermes
ALKS
|
$83.6M |
Top Sells
| 1 |
Thermo Fisher Scientific
TMO
|
$128M |
| 2 |
MoonLake Immunotherapeutics
MLTX
|
$28.5M |
| 3 |
Illumina
ILMN
|
$25.8M |
| 4 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$24.8M |
| 5 |
scPharmaceuticals
SCPH
|
$23.5M |
Sector Composition
| 1 | Healthcare | 99.98% |
| 2 | Financials | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWAV
51
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $12.4M | 0.19% |
65,060
-58,940
| -48% | -$11.2M |
|
52
Tourmaline Bio
TRML
$645M
| $10.4M | 0.16% |
+398,850
| New | +$10.4M |
|
53
Adicet Bio
ACET
$60.8M
| $7.81M | 0.12% |
4,134,631
-106,841
| -3% | -$202K |
|
|
SLRN
54
DELISTED
ACELYRIN
SLRN
| $7.3M | 0.11% |
978,310
| – | – |
|
55
Immunic
IMUX
$79.4M
| $6.5M | 0.1% |
4,335,255
| – | – |
|
|
CUTR
56
DELISTED
Cutera, Inc.
CUTR
| $6.41M | 0.1% |
1,817,585
-29,011
| -2% | -$102K |
|
57
SAB Biotherapeutics
SABS
$21.6M
| $6.31M | 0.1% |
+9,178,282
| New | +$6.31M |
|
58
Milestone Pharmaceuticals
MIST
$151M
| $5.44M | 0.08% |
3,256,102
| – | – |
|
59
Exagen
XGN
$213M
| $2.99M | 0.05% |
1,504,602
+12,170
| +0.8% | +$24.2K |
|
60
Apyx Medical
APYX
$71.9M
| $2.69M | 0.04% |
1,025,963
-751,231
| -42% | -$1.97M |
|
|
ARYD
61
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
| $1.39M | 0.02% |
127,970
| – | – |
|
62
Sight Sciences
SGHT
$199M
| $850K | 0.01% |
+164,806
| New | +$850K |
|
63
Rocket Pharmaceuticals, Inc. Warrant
RCKTW
$4.17M
| $172K | ﹤0.01% |
350,000
| – | – |
|
|
SIEN
64
DELISTED
Sientra, Inc.
SIEN
| $49.4K | ﹤0.01% |
81,016
-223,020
| -73% | -$136K |
|
|
DMTK
65
DELISTED
DermTech, Inc. Common Stock
DMTK
| – | – |
-2,718,356
| Closed | -$3.91M |
|
|
AKYA
66
DELISTED
Akoya BioSciences
AKYA
| – | – |
-338,422
| Closed | -$1.57M |
|
67
Design Therapeutics
DSGN
$339M
| – | – |
-2,512,986
| Closed | -$5.93M |
|
|
68
Illumina
ILMN
$15.2B
| – | – |
-188,125
| Closed | -$25.8M |
|
|
69
MoonLake Immunotherapeutics
MLTX
$3.78B
| – | – |
-500,000
| Closed | -$28.5M |
|
70
Mineralys Therapeutics
MLYS
$1.94B
| – | – |
-922,100
| Closed | -$8.77M |
|
71
Outset Medical
OM
$245M
| – | – |
-808,658
| Closed | -$8.8M |
|
72
PMV Pharmaceuticals
PMVP
$82.1M
| – | – |
-2,375,785
| Closed | -$14.6M |
|
73
Relmada Therapeutics
RLMD
$48.8M
| – | – |
-2,131,835
| Closed | -$6.4M |
|
|
74
scPharmaceuticals
SCPH
$296M
| – | – |
-3,297,843
| Closed | -$23.5M |
|
75
Sagimet Biosciences
SGMT
$239M
| – | – |
-400,277
| Closed | -$3.52M |
|